Ed Arce's Stock Ratings

HC Wainwright & Co. Analyst

Ed Arce is an analyst at HC Wainwright & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/27/2024

Overall Average Return

0.92%

Smart Score

55.8%

Overall Average Return Percentile

40th

Number of Ratings

287
date
▲▼
ticker
▲▼
Buy Now
Company
▲▼
Current price
▲▼
Upside/Downside
▲▼
Analyst Firm
▲▼
Analyst & % Accurate
▲▼
Price Target Change
▲▼
Rating Change
▲▼
Previous / Current Rating
▲▼
Get Alert
04/24/2024TVTXBuy Now
Travere Therapeutics
$5.26261.22%HC Wainwright & Co.
Ed Arce55%
$17 → $19MaintainsBuyGet Alert
04/09/2024GALTBuy Now
Galectin Therapeutics
$3.68198.91%HC Wainwright & Co.
Ed Arce55%
 → $11ReiteratesBuy → BuyGet Alert
04/08/2024CDTXBuy Now
Cidara Therapeutics
$12.70-52.76%HC Wainwright & Co.
Ed Arce55%
$120 → $120MaintainsBuyGet Alert
04/05/2024GNFTBuy Now
Genfit
$3.49215.19%HC Wainwright & Co.
Ed Arce55%
 → $11ReiteratesBuy → BuyGet Alert
04/02/2024MIRMBuy Now
Mirum Pharmaceuticals
$24.46137.12%HC Wainwright & Co.
Ed Arce55%
$58 → $58MaintainsBuyGet Alert
04/01/2024GALTBuy Now
Galectin Therapeutics
$3.68198.91%HC Wainwright & Co.
Ed Arce55%
 → $11ReiteratesBuy → BuyGet Alert
04/01/2024ITRMBuy Now
Iterum Therapeutics
$1.63268.1%HC Wainwright & Co.
Ed Arce55%
 → $6ReiteratesBuy → BuyGet Alert
04/01/2024IVABuy Now
Inventiva
$3.28570.73%HC Wainwright & Co.
Ed Arce55%
 → $22ReiteratesBuy → BuyGet Alert
04/01/2024ASMBBuy Now
Assembly Biosciences
$12.70—HC Wainwright & Co.
Ed Arce55%
—Reiterates → NeutralGet Alert
04/01/2024UNCYBuy Now
Unicycive Therapeutics
$1.06324.53%HC Wainwright & Co.
Ed Arce55%
 → $4.5ReiteratesBuy → BuyGet Alert
03/28/2024AKBABuy Now
Akebia Therapeutics
$1.33351.03%HC Wainwright & Co.
Ed Arce55%
$5 → $6MaintainsBuyGet Alert
03/28/2024DRRXBuy Now
Durect
$0.91—HC Wainwright & Co.
Ed Arce55%
—Reiterates → NeutralGet Alert
03/27/2024ETNBBuy Now
89bio
$8.33272.15%HC Wainwright & Co.
Ed Arce55%
$31 → $31MaintainsBuyGet Alert
03/26/2024ZVSABuy Now
ZyVersa Therapeutics
$4.87146.41%HC Wainwright & Co.
Ed Arce55%
 → $240ReiteratesBuy → BuyGet Alert
03/20/2024SYBXBuy Now
Synlogic
$1.84—HC Wainwright & Co.
Ed Arce55%
—UpgradeSell → NeutralGet Alert
03/20/2024IVABuy Now
Inventiva
$3.28570.73%HC Wainwright & Co.
Ed Arce55%
 → $22ReiteratesBuy → BuyGet Alert
03/19/2024ACXPBuy Now
Acurx Pharmaceuticals
$2.01497.01%HC Wainwright & Co.
Ed Arce55%
$14 → $12MaintainsBuyGet Alert
03/15/2024MDGLBuy Now
Madrigal Pharmaceuticals
$193.00120.21%HC Wainwright & Co.
Ed Arce55%
$405 → $425MaintainsBuyGet Alert
03/15/2024AKBABuy Now
Akebia Therapeutics
$1.33275.86%HC Wainwright & Co.
Ed Arce55%
 → $5ReiteratesBuy → BuyGet Alert

Recent Analyst Stock Rating News

Galectin Therapeutics And 2 Other Penny Stocks Insiders Are Buying
Critical Insights From Travere Therapeutics Analyst Ratings: What You Need To Know
Analyst Ratings For Mirum Pharmaceuticals
Cracking The Code: Understanding Analyst Reviews For Mirum Pharmaceuticals
Peeling Back The Layers: Exploring Travere Therapeutics Through Analyst Insights
The Analyst Verdict: Arcturus Therapeutics In The Eyes Of 4 Experts
Critical Insights From Mirum Pharmaceuticals Analyst Ratings: What You Need To Know
Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Deep Dive Into Travere Therapeutics Stock: Analyst Perspectives (7 Ratings)
Cracking The Code: Understanding Analyst Reviews For Travere Therapeutics
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free